药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dobutamine
Hydroxychloroquine
The risk or severity of adverse effects can be increased when Dexamethasone is combined with Hydroxychloroquine.
Dobutamine
Stepronin
The risk or severity of adverse effects can be increased when Dexamethasone is combined with Stepronin.
Dobutamine
Nelarabine
The risk or severity of adverse effects can be increased when Dexamethasone is combined with Nelarabine.
Dobutamine
Decitabine
The risk or severity of adverse effects can be increased when Dexamethasone is combined with Decitabine.
Dobutamine
Eculizumab
The risk or severity of adverse effects can be increased when Dexamethasone is combined with Eculizumab.
Dobutamine
Lomustine
The risk or severity of adverse effects can be increased when Lomustine is combined with Dexamethasone.
Dobutamine
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Dexamethasone.
Dobutamine
Capecitabine
The risk or severity of adverse effects can be increased when Capecitabine is combined with Dexamethasone.
Dobutamine
Flucytosine
The risk or severity of adverse effects can be increased when Flucytosine is combined with Dexamethasone.
Dobutamine
Mycophenolic acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Dexamethasone.
Dobutamine
Hydroxyurea
The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Dexamethasone.
Dobutamine
Azacitidine
The risk or severity of adverse effects can be increased when Azacitidine is combined with Dexamethasone.
Dobutamine
Temozolomide
The risk or severity of adverse effects can be increased when Temozolomide is combined with Dexamethasone.
Dobutamine
Dacarbazine
The risk or severity of adverse effects can be increased when Dacarbazine is combined with Dexamethasone.
Dobutamine
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Dexamethasone.
Hydroxypropyl cellulose
Satralizumab
The serum concentration of Metoclopramide can be decreased when it is combined with Satralizumab.
Hydroxypropyl cellulose
Oliceridine
The risk or severity of serotonin syndrome can be increased when Metoclopramide is combined with Oliceridine.
Hydroxypropyl cellulose
Abametapir
The serum concentration of Metoclopramide can be increased when it is combined with Abametapir.
Hydroxypropyl cellulose
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Metoclopramide.
Hydroxypropyl cellulose
Cenobamate
The serum concentration of Metoclopramide can be decreased when it is combined with Cenobamate.